Alvarado-Esquivel C, Arellano-Santos CV, Salazar-Arana JL, Mercado-Suárez MF

Language: Spanish
References: 18
Page: 447-450
PDF size: 60.69 Kb.

ABSTRACT

Objective. We carried out an observational, descriptive, and retrospective epidemiological study in order to determine the prevalence of hepatitis B virus infection (HBV) in patients with acute and chronic liver disease in three public hospitals of Durango, Mexico.
Matherial and methods. Sixty five adult patients were included in the study. Fifty eight (89%) were inpatients and 7 were outpatients. Twenty three patients suffered from acute hepatitis, 10 chronic hepatitis, 29 liver cirrhosis, 2 hepatocellular carcinoma, and 1 fulminant hepatitis. A questionnaire was administered to all participants that included sociodemographic and epidemiological data. In addition, serum samples were analyzed for hepatitis B surface antigen (HBsAg) by an immunoassay (AUZYME Monoclonal), manufactured by ABBOTT Diagnostics (North Chicago, IL, USA).
Results. Out of the 65 patients, 2 (3%) were positive for HBsAg. Of the two positive cases, one had chronic hepatitis and other liver cirrhosis. Both positive cases had histories of blood transfusion, surgery, and alcohol abuse. In addition, one of them had a history of acupuncture. Previous traveling (within Mexico, abroad or both) was more frequently observed in HBsAg positive patients than in HBsAg negative patients (p ‹0.05).
Conclusion. We concluded that the prevalence of HBV infection in patients with liver disease in the city of Durango is low. This prevalence is comparable or lower than the one reported in other Mexican cities, and lower than other countries.

REFERENCES

1. Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004;8:255-266.

2. Pol S. Epidemiology and natural history of hepatitis B. Rev Prat 2005;55:599-606.

3. Rawls RA, Vega KJ. Viral hepatitis in minority America. J Clin Gastroenterol 2005;39:144-151.

4. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38 (Suppl):S158-168.

5. Ranger-Rogez S, Denis F. Hepatitis B mother—to—child transmission. Expert Rev Anti Infect Ther 2004;2:133-145.

6. Tang S, Lai KN. Chronic viral hepatitis in hemodialysis patients. Hemodial Int 2005;9:169-179.

7. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000;18 (Suppl 1):S17-19.

8. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000;61:362-366.

9. Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, et al. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Am J Trop Med Hyg 1995;52:293-296.

10. Neamtu A, Pascu O, Szanto P, Chira O, Neamtu D, State D. The role of the hepatitis B, C and D viruses in the etiology of chronic hepatopathies in Cluj. Bacteriol Virusol Parazitol Epidemiol 1995;40:119-123.

11. Shrestha SM, Tsuda F, Okamoto H, Tokita H, Horikita M, Tanaka T, et al. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal. Hepatology 1994;19:805-809.

12. Souto Meirino CA, Simón Domínguez J, Pulido Priego M de L, Hernández Pérez A, García Hernández IC, del Río Chiriboga CA. The prevalence of markers for hepatitis A, B and C in a hospital in Mexico. Salud Publica Mex 1994;36:257-262.

13. Frías Salcedo JA, López Cruz J, Benavides Aguilar O, Imperial Hernández E, Olivera Orozco JG. Informe de marcadores serológicos de las hepatitis virales en el Hospital Central Militar. Rev Sanid Milit 1995;49:10-13.

14. Campollo O, Valencia Salinas JJ, Berumen Arellano A, Pérez Aranda MA, Panduro Cerda A, Segura Ortega J. Epidemiological characteristics of liver cirrhosis at the Hospital Civil of Guadalajara. Salud Publica Mex 1997;39:195-200.

15. Méndez Sánchez N, Aguilar Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004;3:30-33.

16. Giusti G, Sagnelli E, Gallo C, Piccinino F, Galanti B, Gaeta GB. The etiology of chronic hepatitis in Italy: a multicenter study, Hepatogastroenterology 1994;41:397-400.

17. Nishioka S de A, Gyorkos TW, Joseph L, Collet JP, Maclean JD. Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed. Epidemiol Infect 2002;128:63-71.

18. Lau DT, Hewlett AT. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Am J Med 2005;118(Suppl 10A):28S-33S.